OTCMKTS:RLFTF

Relief Therapeutics Competitors

$0.23
-0.01 (-2.54 %)
(As of 06/18/2021 03:59 PM ET)
Add
Compare
Today's Range
$0.23
$0.24
50-Day Range
$0.19
$0.31
52-Week Range
$0.02
$0.95
Volume2.25 million shs
Average Volume9.18 million shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Relief Therapeutics (OTCMKTS:RLFTF) Vs. DDXS, TNGN, ATTBF, AGNPF, LBTSF, and CBDC

Should you be buying RLFTF stock or one of its competitors? Companies in the industry of "biotechnology" are considered alternatives and competitors to Relief Therapeutics, including (DDXS) (DDXS), (TNGN) (TNGN), Abattis Bioceuticals (ATTBF), Algernon Pharmaceuticals (AGNPF), Almirall (LBTSF), and Apotheca Biosciences (CBDC).

(DDXS) (OTCMKTS:DDXS) and Relief Therapeutics (OTCMKTS:RLFTF) are both health technology companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, analyst recommendations, earnings, profitability, valuation, risk and institutional ownership.

Profitability

This table compares (DDXS) and Relief Therapeutics' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
(DDXS)N/AN/AN/A
Relief TherapeuticsN/AN/AN/A

Analyst Ratings

This is a breakdown of current ratings and target prices for (DDXS) and Relief Therapeutics, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
(DDXS)0000N/A
Relief Therapeutics0000N/A

Valuation and Earnings

This table compares (DDXS) and Relief Therapeutics' top-line revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
(DDXS)N/AN/AN/AN/AN/A
Relief TherapeuticsN/AN/AN/AN/AN/A

(TNGN) (OTCMKTS:TNGN) and Relief Therapeutics (OTCMKTS:RLFTF) are both health technology companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, analyst recommendations, earnings, profitability, valuation, risk and institutional ownership.

Profitability

This table compares (TNGN) and Relief Therapeutics' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
(TNGN)N/AN/AN/A
Relief TherapeuticsN/AN/AN/A

Analyst Ratings

This is a breakdown of current ratings and target prices for (TNGN) and Relief Therapeutics, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
(TNGN)0000N/A
Relief Therapeutics0000N/A

Valuation and Earnings

This table compares (TNGN) and Relief Therapeutics' top-line revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
(TNGN)N/AN/AN/AN/AN/A
Relief TherapeuticsN/AN/AN/AN/AN/A

Abattis Bioceuticals (OTCMKTS:ATTBF) and Relief Therapeutics (OTCMKTS:RLFTF) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, analyst recommendations, earnings, profitability, valuation, risk and institutional ownership.

Profitability

This table compares Abattis Bioceuticals and Relief Therapeutics' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Abattis BioceuticalsN/AN/AN/A
Relief TherapeuticsN/AN/AN/A

Valuation and Earnings

This table compares Abattis Bioceuticals and Relief Therapeutics' top-line revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Abattis BioceuticalsN/AN/AN/AN/AN/A
Relief TherapeuticsN/AN/AN/AN/AN/A

Analyst Ratings

This is a breakdown of current ratings and target prices for Abattis Bioceuticals and Relief Therapeutics, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Abattis Bioceuticals0000N/A
Relief Therapeutics0000N/A

Relief Therapeutics (OTCMKTS:RLFTF) and Algernon Pharmaceuticals (OTCMKTS:AGNPF) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their dividends, analyst recommendations, risk, institutional ownership, earnings, valuation and profitability.

Profitability

This table compares Relief Therapeutics and Algernon Pharmaceuticals' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Relief TherapeuticsN/AN/AN/A
Algernon PharmaceuticalsN/AN/AN/A

Valuation and Earnings

This table compares Relief Therapeutics and Algernon Pharmaceuticals' gross revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Relief TherapeuticsN/AN/AN/AN/AN/A
Algernon PharmaceuticalsN/AN/AN/AN/AN/A

Analyst Ratings

This is a summary of recent recommendations for Relief Therapeutics and Algernon Pharmaceuticals, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Relief Therapeutics0000N/A
Algernon Pharmaceuticals0000N/A

Relief Therapeutics (OTCMKTS:RLFTF) and Almirall (OTCMKTS:LBTSF) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their dividends, analyst recommendations, risk, institutional ownership, earnings, valuation and profitability.

Profitability

This table compares Relief Therapeutics and Almirall's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Relief TherapeuticsN/AN/AN/A
AlmirallN/AN/AN/A

Valuation and Earnings

This table compares Relief Therapeutics and Almirall's gross revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Relief TherapeuticsN/AN/AN/AN/AN/A
AlmirallN/AN/AN/AN/AN/A

Analyst Ratings

This is a summary of recent recommendations for Relief Therapeutics and Almirall, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Relief Therapeutics0000N/A
Almirall01102.50

Summary

Almirall beats Relief Therapeutics on 1 of the 1 factors compared between the two stocks.

Relief Therapeutics (OTCMKTS:RLFTF) and Apotheca Biosciences (NASDAQ:CBDC) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their dividends, analyst recommendations, risk, institutional ownership, earnings, valuation and profitability.

Profitability

This table compares Relief Therapeutics and Apotheca Biosciences' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Relief TherapeuticsN/AN/AN/A
Apotheca BiosciencesN/AN/AN/A

Valuation and Earnings

This table compares Relief Therapeutics and Apotheca Biosciences' gross revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Relief TherapeuticsN/AN/AN/AN/AN/A
Apotheca BiosciencesN/AN/AN/AN/AN/A

Analyst Ratings

This is a summary of recent recommendations for Relief Therapeutics and Apotheca Biosciences, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Relief Therapeutics0000N/A
Apotheca Biosciences0000N/A


Relief Therapeutics Competitors List

Competitor NameCompetitor BTM RankCompetitor PriceCompetitor Price ChangeCompetitor Market CapCompetitor RevenueCompetitor P/E RatioCompetitor Indicator(s)
(DDXS) logo
DDXS
(DDXS)
0.5$0.00-0.0%$0.00N/A0.00
TNGN
(TNGN)
0.4N/AN/A$0.00N/A0.00Gap Down
Abattis Bioceuticals logo
ATTBF
Abattis Bioceuticals
0.4$0.02-8.0%$0.00N/A0.00Gap Up
Algernon Pharmaceuticals logo
AGNPF
Algernon Pharmaceuticals
0.0$0.11-6.1%$0.00N/A0.00Gap Down
Almirall logo
LBTSF
Almirall
0.5$15.15-0.0%$0.00N/A0.00
Apotheca Biosciences logo
CBDC
Apotheca Biosciences
0.4$0.05-0.0%$0.00N/A0.00
ARNI
Arno Therapeutics
0.5$0.01-0.0%$0.00N/A0.00
ASCLF
Ascletis Pharma
0.4$0.05-0.0%$0.00N/A0.00
AXIM Biotechnologies logo
AXIM
AXIM Biotechnologies
0.4$0.85-5.9%$0.00N/A0.00News Coverage
BXRXV
Baudax Bio
0.5$4.51-22.2%$0.00N/A0.00High Trading Volume
BerGenBio ASA logo
BRRGF
BerGenBio ASA
0.7$3.50-0.0%$0.00N/A0.00
Cannabics Pharmaceuticals logo
CNBX
Cannabics Pharmaceuticals
0.4$0.20-4.5%$0.00N/A0.00Gap Up
ORHOF
CannaRoyalty
0.7$9.23-56.1%$0.00N/A0.00Gap Up
CPPSF
Cassiopea
0.5$54.50-0.0%$0.00N/A0.00Decrease in Short Interest
Cerebain Biotech logo
CBBT
Cerebain Biotech
0.0$0.00-16.3%$0.00N/A0.00Gap Up
CGYG
China Longyi Group International
0.4$0.00-0.0%$0.00N/A0.00High Trading Volume
Claritas Pharmaceuticals logo
KALTF
Claritas Pharmaceuticals
0.6$0.03-22.5%$0.00N/A0.00Gap Up
CLVLY
Clinuvel Pharmaceuticals
1.0$21.60-5.0%$0.00N/A0.00Gap Up
CELZ
Creative Medical Technology
0.5$0.04-3.9%$0.00N/A0.00
Eastgate Biotech logo
ETBI
Eastgate Biotech
0.5$0.00-0.0%$0.00N/A0.00
EMMBF
Emblem
0.6$1.40-1.4%$0.00N/A0.00
ENZC
Enzolytics
0.0$0.19-7.5%$0.00N/A0.00
GB Sciences logo
GBLX
GB Sciences
0.5$0.05-7.0%$0.00N/A0.00Gap Up
Genfit logo
GNFTF
Genfit
0.5$3.81-0.9%$0.00N/A0.00
GMXAY
GENMAB A/S/S
0.5$42.92-1.4%$0.00N/A0.00
GenSight Biologics logo
GSGTF
GenSight Biologics
1.0$10.90-0.9%$0.00N/A0.00
Genus logo
GENSF
Genus
0.7$72.50-0.0%$0.00N/A0.00
HALB
Halberd
0.0$0.03-1.9%$0.00N/A0.00News Coverage
HAVN Life Sciences logo
HAVLF
HAVN Life Sciences
0.0$0.53-0.2%$0.00N/A0.00
Idorsia logo
IDRSF
Idorsia
0.5$29.89-0.0%$0.00N/A0.00
IPATF
ImmunoPrecise Antibodies
0.5$18.70-0.5%$0.00N/A0.00High Trading Volume
IMLFF
InMed Pharmaceuticals
0.6N/AN/A$0.00N/A0.00High Trading Volume
Innovation Pharmaceuticals logo
IPIX
Innovation Pharmaceuticals
0.6$0.21-1.3%$0.00N/A0.00
JANX
Janux Therapeutics
0.0$21.10-6.7%$0.00N/A0.00Gap Down
Medican Enterprises logo
MDCN
Medican Enterprises
0.5$0.00-0.0%$0.00N/A0.00Gap Down
Mesoblast logo
MEOBF
Mesoblast
0.5$1.74-6.3%$0.00N/A0.00Gap Up
MCURF
Mind Cure Health
0.0$0.36-3.4%$0.00N/A0.00High Trading Volume
Mind Medicine (MindMed) logo
MMEDF
Mind Medicine (MindMed)
1.1$3.74-1.3%$0.00N/A0.00High Trading Volume
Molecular Partners logo
MLLCF
Molecular Partners
0.5$18.97-5.5%$0.00N/A0.00Gap Up
MorphoSys logo
MPSYF
MorphoSys
0.0$84.75-0.0%$0.00N/A0.00Decrease in Short Interest
NRNVF
Nordic Nanovector ASA
0.0$1.64-0.0%$0.00N/A0.00High Trading Volume
Novozymes A/S logo
NVZMF
Novozymes A/S
0.4$71.65-0.0%$0.00N/A0.00
BPSR
Organicell Regenerative Medicine
0.5$0.14-1.1%$0.00N/A0.00Gap Up
Oxurion logo
TBGNF
Oxurion
0.5$2.94-0.0%$0.00N/A0.00
Pharnext logo
PNEXF
Pharnext
0.3$2.00-0.0%$0.00N/A0.00
PTEO
Proteo
0.5$0.09-0.0%$0.00N/A0.00
PROT
Proteonomix
0.5$0.00-0.0%$0.00N/A0.00
ProtoKinetix logo
PKTX
ProtoKinetix
0.5$0.17-5.8%$0.00N/A0.00Gap Up
PureTech Health logo
PTCHF
PureTech Health
0.0$5.18-4.9%$0.00N/A0.00Gap Up
RCPHF
Recipharm AB (publ)
1.0$16.05-0.0%$0.00N/A0.00High Trading Volume
This page was last updated on 6/21/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.